Systematic identification of clinically relevant miRNAs for potential miRNA-based therapy in lung adenocarcinoma

• Ngā kaituhi matua: Shu-Hsuan Liu (Author), Kai-Wen Hsu (Author), Yo-Liang Lai (Author), Yu-Feng Lin (Author), Fang-Hsin Chen (Author), Pei-Hwa Peng (Author), Li-Jie Lin (Author), Heng-Hsiung Wu (Author), Chia-Yang Li (Author), Shu-Chi Wang (Author), Min-Zu Wu (Author), Yuh-Pyng Sher (Author), Wei-Chung Cheng (Author)
• Hōputu: Pukapuka
• I whakaputaina: Elsevier, 2021-09-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Lung adenocarcinoma (LUAD), the most common histological type of non-small cell lung cancer, is one of the most malignant and deadly diseases. Current treatments for advanced LUAD patients are far from ideal and require further improvements. Here, we utilized a systematic integrative analysis of LUA...